GO:0016992 lipoate synthase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0016992 (lipoate synthase activity) catalyzes the insertion of two sulfur atoms into an octanoyl-lysine residue on a target protein to form a dihydrolipoyl group, using S-adenosyl-L-methionine and a [4Fe-4S] cluster as the sulfur donor.
• The reaction is a radical SAM mechanism that consumes two SAM molecules, generates two 5'-deoxyadenosine and two methionine molecules, and requires a second [4Fe-4S] cluster on a scaffold protein plus reduced ferredoxin.
• Lipoate synthase (LipA) is the key enzyme for de novo lipoylation of mitochondrial and bacterial proteins, and its activity is essential for the function of pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, and glycine cleavage system H protein.
• In some organisms, a lipoyl-relay pathway involving lipoate-protein ligase (LplA) can bypass LipA for lipoylation, highlighting metabolic flexibility and potential drug targets.
• Dysregulation of lipoylation is linked to metabolic disorders, neurodegeneration, and cancer, making lipoate synthase an emerging target for therapeutic intervention.
• CRISPR knockout, point-mutation, and knock-in models of LipA and related genes enable precise dissection of lipoylation pathways in diverse organisms.
Description
Lipoate synthase activity (GO:0016992) is a molecular function that catalyzes the final step in the de novo biosynthesis of lipoic acid, a sulfur-containing cofactor essential for oxidative metabolism. This enzyme, commonly known as LipA, belongs to the radical S-adenosylmethionine (SAM) superfamily and uses a [4Fe-4S] cluster to insert sulfur atoms into an octanoyl-lysine residue on target proteins, converting it to a dihydrolipoyl group. The reaction is critical for the assembly of multienzyme complexes such as pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase, which are central to cellular energy production. Researchers study lipoate synthase to understand mitochondrial metabolism, bacterial pathogenesis, and the potential for developing antimicrobials or metabolic modulators. The enzyme's unique radical chemistry and its role in diverse organisms, from bacteria to humans, make it a compelling subject for structural, biochemical, and genetic investigations.
lipoate synthase activity At A Glance
| GO ID | GO:0016992 |
|---|---|
| GO term | lipoate synthase activity |
| Ontology | molecular_function |
| Synonym | LipA, lipoic acid synthase, lipoyl synthase activity, LS, protein 6-N-(octanoyl)lysine:sulfur sulfurtransferase activity, protein N6-(octanoyl)lysine:sulfur sulfurtransferase activity |
| Major function | Catalyzes the insertion of two sulfur atoms into an octanoyl-lysine residue to form a dihydrolipoyl group on target proteins, using SAM and a [4Fe-4S] cluster. |
| Reaction substrates | N(6)-octanoyl-L-lysyl-[protein], S-adenosyl-L-methionine, oxidized ferredoxin, [4Fe-4S] cluster scaffold protein. |
| Reaction products | N(6)-[(R)-dihydrolipoyl]-L-lysyl-[protein], 5'-deoxyadenosine, L-methionine, hydrogen sulfide, reduced ferredoxin. |
| Cofactors | Two [4Fe-4S] clusters (one on LipA, one on scaffold protein), reduced ferredoxin. |
| Pathway context | De novo lipoic acid biosynthesis, post-translational modification of mitochondrial and bacterial proteins. |
What Is GO:0016992?
Lipoate synthase activity (GO:0016992) is defined as the catalysis of a complex reaction in which a [Fe-S] cluster scaffold protein carrying a second [4Fe-4S]2+ cluster, N(6)-octanoyl-L-lysyl-[protein], two oxidized [2Fe-2S]-ferredoxins, two S-adenosyl-L-methionine molecules, and four protons are converted into the scaffold protein, N(6)-[(R)-dihydrolipoyl]-L-lysyl-[protein], four Fe3+ ions, two hydrogen sulfide molecules, two 5'-deoxyadenosine molecules, two L-methionine molecules, and two reduced [2Fe-2S]-ferredoxins. In simpler terms, this enzyme takes a protein that already has an octanoyl group attached to a lysine residue and replaces two hydrogen atoms with sulfur atoms, forming a dihydrolipoyl group, using SAM as the sulfur donor and a radical mechanism.
Why Is lipoate synthase activity Important in Cell Biology?
Lipoate synthase activity is essential for the de novo biosynthesis of lipoic acid, a cofactor required for the function of key metabolic enzymes such as pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, and the glycine cleavage system. Without lipoylation, these complexes lose activity, leading to impaired energy metabolism and accumulation of toxic metabolites. In humans, mutations in the lipoic acid biosynthesis pathway are associated with severe metabolic disorders, including Leigh syndrome and pyruvate dehydrogenase deficiency. In bacteria, lipoate synthase is a potential target for antibiotics because it is absent in mammals, which acquire lipoic acid from the diet. Furthermore, lipoylation is implicated in cancer metabolism and neurodegeneration, making this enzyme a focus of therapeutic research.
• Essential for oxidative metabolism: lipoylation activates pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase, linking glycolysis and the TCA cycle.
• Required for glycine cleavage: the H protein of the glycine cleavage system requires lipoic acid for its function.
• Antibacterial target: LipA is essential in many bacteria and absent in humans, offering a selective target for new antibiotics.
• Metabolic disorders: defects in lipoylation cause pyruvate dehydrogenase deficiency and Leigh syndrome.
• Cancer metabolism: altered lipoylation supports tumor growth and survival under metabolic stress.
• Neurodegeneration: impaired lipoylation contributes to mitochondrial dysfunction in neurons.
• Biotechnological applications: engineering lipoate synthase can enhance production of lipoic acid and related compounds.
• Model for radical SAM enzymology: LipA is a paradigm for understanding radical SAM mechanisms and Fe-S cluster chemistry.
• Evolutionary diversity: lipoate synthase is found in bacteria, archaea, and eukaryotes, with variations in accessory pathways.
• Drug discovery: small-molecule inhibitors of LipA are being explored for antimicrobial and anticancer therapy.
Mechanism, Genes and Research Methods
Substrate Recognition and Octanoyl Transfer
In simple terms: First, the enzyme finds a protein that already has a fatty acid tail attached and gets ready to modify it.
Lipoate synthase acts on proteins that have been previously modified with an octanoyl group on a specific lysine residue. This octanoyl group is typically transferred by lipoyltransferase (LipB) in bacteria or by a similar enzyme in mitochondria. The octanoyl-lysyl-protein serves as the substrate for LipA, which then inserts sulfur atoms to form the dihydrolipoyl group. The recognition of the target protein is mediated by interactions with the scaffold protein and the specific lysine residue.
Radical SAM Chemistry and Sulfur Insertion
In simple terms: The enzyme uses a radical mechanism to break a sulfur donor molecule and attach sulfur atoms to the protein.
Lipoate synthase is a radical SAM enzyme that contains a [4Fe-4S] cluster. In the presence of S-adenosyl-L-methionine (SAM), the cluster reductively cleaves SAM to generate a 5'-deoxyadenosyl radical, which abstracts a hydrogen atom from the octanoyl substrate. This radical intermediate then undergoes sulfur insertion, with the sulfur atoms derived from a second [4Fe-4S] cluster on the same enzyme or on a scaffold protein. The reaction consumes two SAM molecules per substrate, producing two 5'-deoxyadenosine and two methionine molecules. The process also requires reduced ferredoxin as an electron donor and results in the release of hydrogen sulfide.
Role of the Scaffold Protein and Fe-S Cluster
In simple terms: A helper protein provides a second iron-sulfur cluster that supplies the sulfur atoms for the reaction.
The reaction mechanism involves a second [4Fe-4S] cluster that is carried by a scaffold protein, such as the Fe-S cluster assembly machinery. This cluster serves as the sulfur donor, and its destruction releases Fe3+ ions and hydrogen sulfide. The scaffold protein may be a separate protein or a domain within LipA itself, depending on the organism. In some bacteria, the scaffold protein is encoded by the lipA gene itself, while in others it is a distinct protein. The interplay between the two clusters is essential for catalysis and is a subject of ongoing structural and mechanistic studies.
Regulation and Accessory Pathways
In simple terms: Cells can also get lipoylated proteins through a salvage pathway that uses dietary or recycled lipoic acid.
In addition to de novo synthesis by LipA, many organisms possess a lipoate salvage pathway that uses lipoate-protein ligase (LplA) to attach free lipoic acid to target proteins. This pathway can bypass the need for LipA under certain conditions, such as when lipoic acid is available from the environment or from the diet. In archaea, a lipoyl-relay pathway involving LplA and a lipoyltransferase has been characterized. The interplay between de novo synthesis and salvage pathways is regulated by the availability of lipoic acid and the metabolic state of the cell. Understanding this regulation is important for targeting lipoylation in pathogens and cancer cells.
Key Genes Involved in GO:0016992 lipoate synthase activity
The following genes and proteins are central to lipoate synthase activity and its associated pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| LIAS (LipA) | Encodes lipoate synthase, the enzyme that catalyzes sulfur insertion to form dihydrolipoamide. | Mutations cause pyruvate dehydrogenase deficiency and Leigh syndrome; target for metabolic studies. |
| LIPB (LipB) | Octanoyltransferase that transfers octanoyl groups from acyl-ACP to target proteins prior to LipA action. | Essential for de novo lipoylation in bacteria; knockout leads to lipoic acid auxotrophy. |
| LPLA (LplA) | Lipoate-protein ligase that attaches free lipoic acid to target proteins in the salvage pathway. | Allows bypass of LipA; important for understanding metabolic flexibility. |
| DLD (E3) | Dihydrolipoamide dehydrogenase, a component of multienzyme complexes that requires lipoylation. | Defects cause E3 deficiency and metabolic disorders. |
| PDHA1 | Pyruvate dehydrogenase E1 alpha subunit, a key target of lipoylation. | Mutations cause pyruvate dehydrogenase deficiency; model for lipoylation studies. |
| OGDH | Alpha-ketoglutarate dehydrogenase, requires lipoylation for activity in the TCA cycle. | Dysregulation linked to cancer and neurodegeneration. |
| GCSH | Glycine cleavage system H protein, carries lipoic acid for glycine decarboxylation. | Defects cause non-ketotic hyperglycinemia. |
| LIAS (mitochondrial) | Mitochondrial isoform of lipoate synthase. | Target for studying mitochondrial lipoylation and disease. |
| LipA (bacterial) | Bacterial lipoate synthase, essential for lipoylation in many pathogens. | Antibacterial target; knockout attenuates virulence. |
| LipM | Octanoyltransferase in some Gram-positive bacteria, alternative to LipB. | Species-specific differences in lipoylation pathways. |
| LipL | Lipoyltransferase that uses lipoyl-ACP for protein lipoylation in some bacteria. | Alternative route for lipoylation; potential drug target. |
| NFU1 | Iron-sulfur cluster scaffold protein involved in LipA maturation. | Mutations cause multiple mitochondrial dysfunction syndrome. |
| ISCU | Iron-sulfur cluster assembly protein required for LipA cluster formation. | Defects lead to mitochondrial disease. |
| Fdx (ferredoxin) | Electron donor for the radical SAM reaction. | Redox regulation of lipoate synthase activity. |
| SAM (metabolite) | S-adenosylmethionine, the sulfur donor and radical initiator. | Links methionine metabolism to lipoylation. |
| Lipoic acid | End product of the pathway, essential cofactor. | Supplementation can rescue some defects. |
| H protein | Glycine cleavage system H protein, a lipoylated protein. | Model substrate for studying lipoylation. |
How Is lipoate synthase activity Regulated?
Lipoate synthase activity is regulated at multiple levels. In bacteria, the expression of lipA is controlled by the availability of lipoic acid and the metabolic state, often through transcriptional regulators such as LipR or via riboswitches. In eukaryotes, the mitochondrial lipoate synthase is encoded by the LIAS gene, and its expression is regulated by mitochondrial biogenesis factors such as PGC-1alpha. The activity of LipA is also dependent on the availability of iron-sulfur cluster assembly machinery, which is regulated by iron levels and oxidative stress. Additionally, the salvage pathway via LplA can compensate for loss of LipA, and its expression is induced when lipoic acid is available. Post-translational modifications of LipA, such as oxidation of its Fe-S clusters, can inactivate the enzyme under oxidative stress conditions.
lipoate synthase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| LIAS | Pyruvate dehydrogenase deficiency, Leigh syndrome | CRISPR knockout in HEK293T or patient fibroblasts; rescue with lipoic acid |
| LIPB | Lipoic acid auxotrophy in bacteria | Bacterial knockout strains; growth assays |
| LPLA | Salvage pathway defects; metabolic flexibility | Knockout in E. coli or archaea; complementation studies |
| PDHA1 | Pyruvate dehydrogenase deficiency | Point mutations in patient cells; metabolic flux analysis |
| OGDH | Cancer metabolism, neurodegeneration | Overexpression and knockout in cancer cell lines |
Pyruvate Dehydrogenase Deficiency and Leigh Syndrome
Mutations in LIAS, the gene encoding lipoate synthase, cause pyruvate dehydrogenase deficiency and Leigh syndrome, a severe neurodegenerative disorder characterized by bilateral lesions in the basal ganglia and brainstem. These mutations impair the lipoylation of pyruvate dehydrogenase, leading to reduced ATP production and accumulation of lactate. Patients present with developmental delay, hypotonia, and lactic acidosis. Experimental models include patient-derived fibroblasts and CRISPR knockout cell lines, which show reduced lipoylation and can be rescued by lipoic acid supplementation.
Cancer Metabolism
Altered lipoylation is observed in various cancers, where it supports mitochondrial metabolism and tumor growth. Lipoylation of pyruvate dehydrogenase is required for the conversion of pyruvate to acetyl-CoA, a key step for cancer cell proliferation. Inhibition of lipoate synthase has been shown to reduce tumor growth in preclinical models, suggesting that targeting this enzyme could be a therapeutic strategy. Furthermore, metabolic engineering of lipoic acid production in bacteria has implications for cancer research.
Bacterial Infections and Antibiotic Development
Lipoate synthase is essential for the survival of many pathogenic bacteria, including Staphylococcus aureus and Mycobacterium tuberculosis, because they rely on de novo lipoic acid synthesis. Inhibitors of LipA have shown antibacterial activity, and knockout of lipA attenuates virulence in animal models. The absence of LipA in humans makes it an attractive target for selective antibiotics. Research is focused on developing small-molecule inhibitors that block the radical SAM mechanism.
From lipoate synthase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of LipA impair mitochondrial metabolism? | CRISPR knockout of LIAS in HEK293T or HeLa cells; Seahorse assay |
| Can a point mutation in the active site abolish enzyme activity? | CRISPR knock-in of catalytic residue mutation (e.g., Cys to Ala) in LIAS |
| Does lipoic acid supplementation rescue lipoylation defects? | Knockout cells treated with lipoic acid; Western blot for lipoylated proteins |
| What is the role of LipA in bacterial virulence? | Bacterial knockout of lipA; infection model in mice |
| Can we visualize LipA localization in live cells? | Knock-in of fluorescent tag (e.g., GFP) at the endogenous LIAS locus |
| Does overexpression of LipA increase lipoylation? | Overexpression of LIAS in mammalian cells; immunoblot |
How to Study the lipoate synthase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro enzyme assay | Lipoate synthase catalytic activity | Kinetic studies, inhibitor screening |
| Western blot for lipoic acid | Levels of lipoylated proteins | Assessing pathway function in cells |
| CRISPR knockout | Loss-of-function phenotype | Studying essentiality and metabolic effects |
| RNA-seq | Transcriptional changes upon LipA perturbation | Identifying compensatory pathways |
| Proteomics | Global lipoylation status | Discovering novel lipoylated proteins |
| Metabolomics | Metabolic flux and intermediate levels | Assessing impact on central carbon metabolism |
| Crystallography/Cryo-EM | Three-dimensional structure | Mechanistic understanding and drug design |
| Fluorescence microscopy | Subcellular localization | Validating mitochondrial targeting |
Biochemical Assays for Lipoate Synthase Activity
Lipoate synthase activity can be measured in vitro using purified enzyme and substrate proteins. The reaction typically monitors the formation of dihydrolipoamide using Ellman's reagent or by detecting the release of 5'-deoxyadenosine via HPLC. Radioactive labeling with 35S-SAM can also be used to track sulfur incorporation. These assays require anaerobic conditions because the enzyme is oxygen-sensitive. They are essential for kinetic studies and inhibitor screening.
Genetic Approaches: Knockout and Knockdown
CRISPR-Cas9 knockout of LIAS or lipA in cell lines and bacteria is a powerful method to study the consequences of loss of lipoate synthase activity. Knockdown using siRNA or shRNA can be used for transient depletion. These models show reduced lipoylation of target proteins, impaired mitochondrial function, and increased sensitivity to oxidative stress. Complementation with wild-type or mutant LIAS can confirm specificity.
Proteomics and Metabolomics
Mass spectrometry-based proteomics can identify lipoylated proteins and quantify changes in lipoylation status upon LipA manipulation. Metabolomics can measure intermediates such as pyruvate, lactate, and TCA cycle metabolites to assess metabolic flux. These methods provide a systems-level view of the impact of lipoate synthase activity on cellular metabolism.
Imaging and Structural Biology
Fluorescence microscopy of tagged LipA (e.g., GFP knock-in) can reveal its subcellular localization, typically mitochondria in eukaryotes. X-ray crystallography and cryo-EM have provided structures of LipA from various organisms, revealing the radical SAM fold and Fe-S cluster arrangement. These structural insights guide inhibitor design and mechanistic studies.
How CRISPR Can Be Used to Study GO:0016992 lipoate synthase activity
Knockout
CRISPR knockout of LIAS or bacterial lipA generates cell lines or strains that completely lack lipoate synthase activity. These models are used to study the essentiality of lipoylation, metabolic reprogramming, and sensitivity to lipoic acid deprivation. Knockout cells often exhibit reduced mitochondrial respiration and increased glycolysis, which can be rescued by exogenous lipoic acid.
Point Mutation
CRISPR knock-in of specific point mutations in the active site of LIAS (e.g., cysteine residues coordinating the Fe-S cluster) allows precise dissection of the catalytic mechanism. Such mutants can be expressed in a knockout background to assess their ability to support lipoylation and cell growth. This approach is valuable for understanding structure-function relationships.
Knock-in
Knock-in of epitope tags (e.g., FLAG, HA) or fluorescent proteins (e.g., GFP) at the endogenous LIAS locus enables visualization and immunoprecipitation of the enzyme in its native context. This allows studies of protein interactions, localization, and dynamics without overexpression artifacts.
Overexpression
Overexpression of wild-type or mutant LIAS in mammalian cells or bacteria can be used to study gain-of-function effects, such as increased lipoylation of target proteins or enhanced metabolic flux. This is particularly useful for biotechnological applications, such as increasing lipoic acid production in engineered strains.
How EDITGENE Supports lipoate synthase activity Research
Researchers studying lipoate synthase activity-related genes often need to determine whether a candidate gene is causally involved in lipoylation, metabolic regulation, or disease. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models, enabling functional validation and mechanistic studies.
Contact EDITGENE today to design your custom CRISPR model for lipoate synthase activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID |
|---|
Frequently Asked Questions About lipoate synthase activity
What is lipoate synthase activity?
Lipoate synthase activity (GO:0016992) is the enzymatic function that inserts sulfur atoms into an octanoyl-lysine residue on proteins to form a dihydrolipoyl group, using S-adenosylmethionine and iron-sulfur clusters.
What genes are involved in lipoate synthase activity?
The primary gene is LIAS (LipA), which encodes the enzyme. Other genes include LIPB, LPLA, and genes for Fe-S cluster assembly such as NFU1 and ISCU.
What is the reaction catalyzed by lipoate synthase?
It converts an octanoyl-lysyl-protein to a dihydrolipoyl-lysyl-protein, consuming SAM and producing 5'-deoxyadenosine, methionine, and hydrogen sulfide.
Why is lipoate synthase important for metabolism?
It is required for lipoylation of pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase, which are essential for energy production and biosynthesis.
What diseases are associated with lipoate synthase deficiency?
Mutations in LIAS cause pyruvate dehydrogenase deficiency and Leigh syndrome, leading to severe neurological symptoms.
How can I study lipoate synthase activity in the lab?
Common methods include in vitro enzyme assays, Western blot for lipoylated proteins, CRISPR knockout, and metabolomics.
Is lipoate synthase a good antibiotic target?
Yes, because it is essential in many bacteria but absent in humans, making it a selective target for antimicrobial development.
What is the difference between de novo synthesis and salvage of lipoic acid?
De novo synthesis uses LipA to insert sulfur into octanoyl-proteins, while salvage uses LplA to attach free lipoic acid to proteins.
Can lipoic acid supplementation rescue lipoate synthase defects?
In some cases, yes. Exogenous lipoic acid can be used by the salvage pathway to restore lipoylation and improve mitochondrial function.
What CRISPR models are available for lipoate synthase research?
EDITGENE offers knockout, point mutation, knock-in, and overexpression models for LIAS and related genes, as well as library screening services.
Conclusion
Lipoate synthase activity (GO:0016992) is a fundamental enzymatic function that governs the biosynthesis of lipoic acid, a cofactor critical for central metabolism. Its radical SAM mechanism and essential role in mitochondrial and bacterial physiology make it a focal point for research in metabolic disorders, cancer, and infectious diseases. Advances in CRISPR-based models and biochemical assays continue to unravel the complexities of lipoylation and its regulation. Targeting lipoate synthase holds promise for novel therapeutics, and ongoing studies will further illuminate its potential in health and disease.
References
- 1. Frey PA. 2001. Radical mechanisms of enzymatic catalysis.. Annu Rev Biochem 70:121-48 PMID: 11395404
- 2. Marquet A et al.. 2001. Biosynthesis of biotin and lipoic acid.. Vitam Horm 61:51-101 PMID: 11153271
- 3. Yang R et al.. 2025. Boosting energy metabolism and biosynthesis in diverse organisms by a common bacterial salvage lipoylation protein.. Nat Commun 16(1):7540 PMID: 40813772
- 4. Jin JQ et al.. 2022. A Lipoate-Protein Ligase Is Required for De Novo Lipoyl-Protein Biosynthesis in the Hyperthermophilic Archaeon Thermococcus kodakarensis.. Appl Environ Microbiol 88(13):e0064422 PMID: 35736229
- 6. Scattolini A et al.. 2022. Functional characterization of the first lipoyl-relay pathway from a parasitic protozoan.. Mol Microbiol 117(6):1352-1365 PMID: 35484915
- 8. Xiao J et al.. 2023. Metabolic engineering of Escherichia coli for the production of (R)-α-lipoic acid.. Biotechnol Lett 45(2):273-286 PMID: 36586051
